Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;25(4):2137-2148.
doi: 10.1007/s11030-020-10108-z. Epub 2020 May 30.

Indole-fused spirochromenes as potential anti-tubercular agents: design, synthesis and in vitro evaluation

Affiliations

Indole-fused spirochromenes as potential anti-tubercular agents: design, synthesis and in vitro evaluation

Ashok Dogamanti et al. Mol Divers. 2021 Nov.

Abstract

As part of an ongoing effort to develop new anti-tubercular agents, a series of novel indole-fused spirochromene hybrids (7a-l) were efficiently synthesized in excellent yields by the popular 'Fisher-Indole synthesis' approach. The structure elucidation of the target compounds was carried out by different spectral techniques including 1H-NMR, 13C-NMR, ESI Mass, and FTIR analysis. Additionally, the proposed structure of 7i was proved by single-crystal X-ray analysis. These compounds (7a-l) were screened for in vitro anti-tubercular activity against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain. The results showed that most of the targets exhibited promising antimycobacterial activity with MICs of 1.56-6.25 μg/mL and weak cytotoxicity (19.93-32.16% at 50 μg/mL). Among them, compound 7l was found to be the most active compound (MIC of 1.56 μg/mL) with a good safety profile (32.16% at 50 μg/mL).

Keywords: Indole; Indole-fused spirochromene; Mycobacterium tuberculosis; Spirochromene; X-ray crystal.

PubMed Disclaimer

Similar articles

Cited by

References

    1. World Health Organization, Global tuberculosis report 2019. https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-en... . Accessed 14 Oct 2019
    1. World Health Organization, Global tuberculosis report, 2013. http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf
    1. Kaufmann SHE, Rubin E (2008) Handbook of tuberculosis: clinics, diagnostics, therapy and epidemiology. Wiley, Hoboken - DOI
    1. Espinal MA (2003) The global situation of MDR-TB. Tuberculosis 83:44–51. https://doi.org/10.1016/s1472-9792(02)00058-6 - DOI - PubMed
    1. Lienhardt C, Raviglione M, Spigelman M, Hafner R, Jaramillo E, Hoelscher M, Zumla A, Gheuens J (2012) New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the future. J Infect Dis 205:S241–S249. https://doi.org/10.1093/infdis/jis034 - DOI - PubMed

MeSH terms

LinkOut - more resources